author-photo

Duncan Wheatley

Royal Cornwall Hospital

61

Papers

1845

Citations

Citation Trend

Filter By

Papers (61) Sort By

JournalConferenceOthers

Randomized multicenter trial of 3 weekly cabazitaxel versus weekly paclitaxel chemotherapy in the first-line treatment of HER2 negative metastatic breast cancer (MBC)

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2–) operable breast cancer (BC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Abstract PD14-06: Dynamic changes of PD-L1 and T-cell activation in ECLIPSE: A phase II study investigating preoperative immune combination strategies in untreated, operable ER+ primary breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT-04-01: Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy - ATNEC (ClinicalTrials.gov NCT04109079)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD1-11: Mature survival update of the double-blind placebo-controlled randomised phase II PAKT trial of first-line capivasertib plus paclitaxel for metastatic triple-negative breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 536: Molecular residual disease detection in early stage breast cancer with a personalized sequencing approach

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy (ATNEC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (2)
240P A real-world data analysis: The first United Kingdom experience of cyclin-dependent kinase 4/6 inhibitor in advanced breast cancer in the National Health Service within an access program

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号